Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

0.6999
Delayed Data
As of Feb 10
 +0.004 / +0.57%
Today’s Change
0.29
Today|||52-Week Range
1.59
-0.01%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close0.70
Today’s open0.70
Day’s range0.68 - 0.70
Volume36,412
Average volume (3 months)92,260
Market cap$98.2M
Dividend yield--
Data as of 02/10/2016

Growth & Valuation

Earnings growth (last year)+28.36%
Earnings growth (this year)-2.08%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.51

Competitors

 Today’s
change
Today’s
% change
SMMTSummit Therapeutics ...+0.56+7.53%
AMPEAmpio Pharmaceutical...+0.01+0.52%
PETXAratana Therapeutics...+0.07+2.61%
PRQRProQR Therapeutics N...+0.17+4.31%
Data as of 02/10/2016

Financials

Next reporting dateFebruary 17, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$0.00
Annual profit (last year)-$39.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Marc Steven Hanover
CFO, CAO, Accounting Director &
Controller
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts

Partner Offers